Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. uri icon

Overview

abstract

  • OBJECTIVE AND IMPORTANCE: After developing subarachnoid hemorrhage, patients may deteriorate from a variety of well-known causes, including rebleeding, hydrocephalus, and vasospasm. Many patients now undergo empirical hyperdynamic vasospasm therapy with hypervolemia, induced hypertension, and nimodipine. CLINICAL PRESENTATION: We report two cases of iatrogenic hypertensive encephalopathy occurring during hyperdynamic therapy for cerebral vasospasm after subarachnoid hemorrhage. Hypertensive encephalopathy is a syndrome of rapidly evolving generalized or focal cerebral symptoms occurring in the setting of severe hypertension, which is reversible with antihypertensive therapy. INTERVENTION: The syndrome can be diagnosed in the appropriate clinical setting with computed tomographic or magnetic resonance imaging that demonstrates characteristic findings. In both cases, decreasing the blood pressure resulted in neurological improvement. CONCLUSION: In the setting of induced hypertensive/hypervolemic therapy for vasospasm, hypertensive encephalopathy should be considered as a potentially reversible cause of delayed neurological decline.

publication date

  • May 1, 1999

Research

keywords

  • Blood Pressure
  • Brain Diseases
  • Dobutamine
  • Hypertension
  • Iatrogenic Disease
  • Ischemic Attack, Transient

Identity

Scopus Document Identifier

  • 0032906952

Digital Object Identifier (DOI)

  • 10.1097/00006123-199905000-00097

PubMed ID

  • 10232545

Additional Document Info

volume

  • 44

issue

  • 5